Press Releases

Date Title and Summary Additional Formats
Toggle Summary CHF Solutions Announces Launch of Ultrafiltration Therapy Using Aquadex FlexFlow® System at Beebe Healthcare
EDEN PRAIRIE, Minn. , May 15, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announces that Sussex County, Delaware -based health system, Beebe Healthcare , has initiated offering ultrafiltration therapy using the company’s Aquadex FlexFlow system.
View HTML
Toggle Summary CHF Solutions, Inc. Announces 17 Percent Increase in Revenues for First Quarter 2019 Over Previous Year and Provides Company Update
EDEN PRAIRIE, Minn. , May 07, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the first quarter ended March 31, 2019 , which included the following highlights: Revenue for first quarter ended March 31, 2019 was $1.2 million , an increase of 17 percent
View HTML
Toggle Summary CHF Solutions Welcomes Industry Veteran Nestor Jaramillo as Chief Commercial Officer
EDEN PRAIRIE, Minn. , May 06, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announces it has hired Nestor Jaramillo, Jr. as its new chief commercial officer, effective May 7, 2019 . “Nestor has been a key player in medical device commercialization for more than 20 years and has led
View HTML
Toggle Summary CHF Solutions, Inc. To Announce First Quarter 2019 Financial Results on May 7, 2019
EDEN PRAIRIE, Minn. , April 30, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its first quarter 2019 financial results will be released on Tuesday, May 7, 2019 . The company will host a conference call and webcast at 9:00 AM ET that morning, during which
View HTML
Toggle Summary CHF Solutions to Sponsor CT Theatre Session, “Personalized Medicine: Improving Clinical Outcomes with Novel Fluid Management Strategies” Moderated by Renowned Cardiothoracic Surgeon Daniel Beckles, M.D., Ph.D., at the 2019 AATS Annual Meeting
EDEN PRAIRIE, Minn. , April 23, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced it will be sponsoring a CT Theatre Session at the American Association for Thoracic Surgery Annual Meeting on Monday, May 6, 2019 , 1:00-1:30 pm at the Metro Toronto Convention Center .
View HTML
Toggle Summary CHF Solutions Announces Launch of Ultrafiltration Program at Heart Hospital at Saint Francis
EDEN PRAIRIE, Minn. , April 16, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced that Heart Hospital at Saint Francis has launched an ultrafiltration program using the Aquadex FlexFlow® system to assist in the management of fluid overload in patients following cardiac surgery
View HTML
Toggle Summary CHF Solutions Announces Launch of Ultrafiltration Program at Oklahoma Heart Institute
EDEN PRAIRIE, Minn. , April 09, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced that Oklahoma Heart Institute in Tulsa, Oklahoma , has launched an ultrafiltration program using the Aquadex FlexFlow® system to assist in the management of fluid overload in patients following
View HTML
Toggle Summary CHF Solutions Submits Patent Application for Pediatric Use of Aquadex FlexFlow® System
EDEN PRAIRIE, Minn. , April 03, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the submission of a method of use application to the United States Patent and Trademark Administration for pediatric use of its Aquadex Flex Flow System.
View HTML
Toggle Summary CHF Solutions to Exhibit at The International Society for Heart and Lung Transplantation 2019 Annual Meeting and Scientific Sessions
EDEN PRAIRIE, Minn. , March 28, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced it will be exhibiting at the 2019 Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT ) on April 3-6, 2019 at the Lowes Meeting Complex in
View HTML
Toggle Summary Newly Published Article Demonstrates Ultrafiltration with CHF Solutions’ Aquadex FlexFlow® System Reduces Hospital Costs by Lowering 90-Day Re-admissions and Durations of Stay in Heart Failure Patients
EDEN PRAIRIE, Minn. , March 26, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced the publication of “ Ultrafiltration vs. Diuretics for Treatment of Fluid Overload in Patients with Heart Failure:  A  Hospital Cost Analysis ” in the Journal of Medical Economics showing that the
View HTML